Electronic cigarettes are more effective than other methods based on nicotine-based smoking cessation replacement. To say it is a new research published in the New England Journal of Medicine , coordinated by Peter Hajek. The study was based on the assumption that e-cigarettes are commonly used in attempts to quit smoking, but the evidence is limited regarding their efficacy compared to that of nicotine products approved as smoking cessation treatments.
How smokers were tested
The researchers explain: “We randomly assigned to adults who attend stop-smoking services of the British National Health Service nicotine replacement products of their choice, including product combinations, provided up to 3 months, or an initial pack of cigarettes electronic (a second generation rechargeable electronic cigarette with a nicotine e-liquid bottle [18 mg per milliliter]), with a recommendation for purchase in line with the initial choice “. Treatment included weekly behavioral support for at least 4 weeks. The results were then judged starting from the ability to maintain abstinence for a year (all verified at the level of periodic analyzes). Out of a total of 886 study participants, the 1-year abstinence rate was 18,
Among those with 1-year withdrawal, those in the e-cigarette group were more favorable than those in the nicotine replacement group to continue using the assigned product after week 52 (80% versus 9%). Overall, throat or mouth irritation was reported more frequently in the e-cigarette group (65.3%, vs. 51.2% in the nicotine replacement group) and more frequently nausea in the nicotine replacement group (37, 9%, compared to 31.3% in the e-cigarette group). The e-cigarette group reported a greater decline in the incidence of cough and phlegm production at 52 weeks compared to the nicotine replacement group. There were no significant differences between the groups in the incidence of wheezing or shortness of breath.